Insights

“What is the optimal mix of in-network and out-of-network revenue?” It’s a question often asked by substance abuse treatment provider management teams and investors. Marwood believes there is not a universal optimal mix, but rather the right mix will vary based on local market demand, supply, and reimbursement dynamics, as well as the provider’s capabilities.

With declining inpatient revenues, many hospitals have acquired or developed ancillary health businesses to round out their portfolios in the past 10-15 years.  The rationale for these acquisitions varied by the type of business but has typically been to diversify income, drive inpatient referrals, and raise brand awareness with patients.  Examples of these ancillary service lines include diagnostic services (e.g., lab, imaging, speech and hearing testing), retail pharmacy, post-acute care, and health plans.

On Thursday, November 30th, Marwood will host senior healthcare policy makers, executives, and thought leaders for a series of discussions on health care reform, provider services, Medicaid, and tax reform, among other timely topics.  This our premier event of the year, so please plan to join us.  Panelists and speakers for the event include:

• Keynote Speaker: The Honorable Thomas E. Price, M.D.
• Congressman John Shimkus (R-IL)
• Matt Klitus: CFO and Chief Strategy Officer, MassHealth
• Claudia Schlosberg: Senior Deputy and State Medicare Director for DC’s Dept. of Health Care Finance
• Jerry Rhodes: CEO, Dental Care Alliance
• Scott Burns: CEO, Sanova Dermatology
• Chris Harris: Partner, FFL Partners
• Adam Flisser, MD FACOG: Senior Vice President, Marwood Group
• Erik Komendant: Vice President, Federal Affairs, Association for Accessible Medicines
• Adrienne Morrell: Executive Vice President, Federal and External Affairs, America’s Health Insurance Plans

To register for the event, please contact Carly Cohen at ccohen@marwoodgroup.com.

Throughout 2017, Congress has focused in large part on repealing and replacing the ACA, and that now-stalled process has dominated both news cycles and investor attention.

With Congress back for the fall, however, the legislative agenda will likely focus on non-healthcare priorities for much of the time.  Key items will include keeping the government funded, raising the debt ceiling, providing disaster relief funding, and tax reform.  That said, the Children’s Health Insurance Program (CHIP) must still be authorized and we expect at least some effort toward ACA market stabilization in the early part of the fall.

To request a full copy of the report, please email us at research@marwoodgroup.com